South Korea Mrna Therapeutics Market Size & Outlook

The mrna therapeutics market in South Korea is expected to reach a projected revenue of US$ 1,105.1 million by 2030. A compound annual growth rate of 19.1% is expected of South Korea mrna therapeutics market from 2024 to 2030.
Revenue, 2023 (US$M)
$325.6
Forecast, 2030 (US$M)
$1,105.1
CAGR, 2024 - 2030
19.1%
Report Coverage
South Korea

South Korea mrna therapeutics market highlights

  • The South Korea mrna therapeutics market generated a revenue of USD 325.6 million in 2023 and is expected to reach USD 1,105.1 million by 2030.
  • The South Korea market is expected to grow at a CAGR of 19.1% from 2024 to 2030.
  • In terms of segment, infectious diseases was the largest revenue generating application in 2023.
  • Infectious Diseases is the most lucrative application segment registering the fastest growth during the forecast period.


Mrna therapeutics market data book summary

Market revenue in 2023USD 325.6 million
Market revenue in 2030USD 1,105.1 million
Growth rate19.1% (CAGR from 2023 to 2030)
Largest segmentInfectious diseases
Fastest growing segmentInfectious Diseases
Historical data2021 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationInfectious Diseases
Key market players worldwideModerna Inc, BioNTech SE ADR, CureVac NV Ordinary Shares, Arcturus Therapeutics Holdings Inc, Sanofi SA, GSK PLC, Pfizer Inc, AstraZeneca PLC, Argos Therapeutics, ETHRIS


Other key industry trends

  • In terms of revenue, South Korea accounted for 2.8% of the global mrna therapeutics market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, Japan mrna therapeutics market is projected to lead the regional market in terms of revenue in 2030.
  • China is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,786.3 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

MRNA Therapeutics Market Scope

MRNA Therapeutics Market Companies

Name Profile # Employees HQ Website

South Korea mrna therapeutics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mrna therapeutics market will help companies and investors design strategic landscapes.


Infectious diseases was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the South Korea mrna therapeutics market based on infectious diseases covering the revenue growth of each sub-segment from 2021 to 2030.


The South Korea mRNA therapeutics market is anticipated to grow owing to increasing healthcare expenditure, favorable government initiatives, and growing demand for the mRNA vaccine for influenza and COVID-19.

Moreover, several vaccine manufacturing expansions by market players are expected to fuel the country’s market. For instance, in August 2022, Moderna, Inc. received marketing approval for Spikevax, an mRNA COVID-19 vaccine manufactured by Samsung Biologics locally in South Korea, as an end-to-end contract development & manufacturing service.

Reasons to subscribe to South Korea mrna therapeutics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of South Korea mrna therapeutics market databook

  • Our clientele includes a mix of mrna therapeutics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the South Korea mrna therapeutics market , including forecasts for subscribers. This country databook contains high-level insights into South Korea mrna therapeutics market from 2021 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

South Korea mrna therapeutics market size, by application, 2021-2030 (US$M)

South Korea MRNA Therapeutics Market Outlook Share, 2023 & 2030 (US$M)

South Korea mrna therapeutics market size, by application, 2021-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more